← Evidence map

ArticleFrontiers in immunology2021

The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic.

Priyanka Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

86 papers cite itlatest 60 shown

2021
…
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33767706